Screener
Eligibility screening
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell…
68 US sites in AK, AZ, CA, CO +25
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.